# Click Therapeutics

> Click Therapeutics, Inc. develops, validates and commercializes software as prescription
> medical treatments — the Digital Therapeutics category it named. Founded 2012 in New York
> by David Benshoof Klein. Its AI-enabled platform treats diseases with an underlying
> neurological or behavioral component via smartphone software, used standalone or alongside
> pharmacotherapy (Software-Enhanced Drugs). Click publishes NO public API, developer portal
> or SDK: its software ships as regulated prescription therapeutics, not as a platform.

Generated by the API Evangelist enrichment pipeline (method: generated) from the public
Click Therapeutics website on 2026-08-02. This file is authored by API Evangelist, not by
Click Therapeutics — the provider serves no /llms.txt (HTTP 404 as of 2026-08-02).

## Company

- [Website](https://www.clicktherapeutics.com/): Company home
- [About](https://www.clicktherapeutics.com/about): Founding, mission, leadership
- [Platform](https://www.clicktherapeutics.com/platform): The AI-enabled prescription digital therapeutic platform
- [Products & pipeline](https://www.clicktherapeutics.com/products): Authorized and investigational programs
- [Click SE](https://www.clicktherapeutics.com/click-se): Software-Enhanced Drugs
- [Clinical trials](https://www.clicktherapeutics.com/clinical-trials): Active and completed studies
- [Publications](https://www.clicktherapeutics.com/publications): Peer-reviewed evidence
- [Insights](https://www.clicktherapeutics.com/insights): Company blog
- [News](https://www.clicktherapeutics.com/news): Press releases
- [Collaborate](https://www.clicktherapeutics.com/collaboration): Pharma and payer partnering
- [Careers](https://www.clicktherapeutics.com/careers)
- [Contact](https://www.clicktherapeutics.com/contact): info@ / bd@ / pr@ / ir@clicktherapeutics.com
- [GitHub organization](https://github.com/clicktherapeutics): 7 public repos — 6 forks of third-party
  React Native / gRPC / troposphere components plus one shell utility repo. No SDK, no client
  library, no API specification.

## Programs

- CT-152 (Rejoyn) — major depressive disorder, developed with Otsuka, FDA authorized, launched
- CT-132 — episodic migraine, FDA authorized
- AspyreRx — type 2 diabetes, FDA authorized
- CT-155 — schizophrenia negative symptoms, with Boehringer Ingelheim, Phase 3 pivotal/regulatory
- CT-156 — schizophrenia, Phase 2
- CT-102 — opioid use disorder, Phase 2
- CT-133 (multiple sclerosis), CT-171 (atopic dermatitis), CT-181 (obesity), CT-191 (oncology),
  CT-141/Clickadian (insomnia), CT-111/Clickheart (acute coronary syndrome) — Phase 1 discovery

## API surface

None found. Probed 2026-08-02:

- No api./developer./docs./portal./status./trust. subdomain resolves for clicktherapeutics.com
- /openapi.json, /swagger.json, /api-docs — 404 (Next.js catch-all HTML)
- /.well-known/security.txt, /openid-configuration, /oauth-authorization-server, /api-catalog,
  /ai-plugin.json, /agent-card.json, /agent.json — all 404
- No GraphQL endpoint, no MCP server, no AsyncAPI, no published webhooks
- No first-party package on npm, PyPI, or any registry searched
- No vulnerability disclosure program, security.txt, or trust center

## Legal

- [Privacy policy](https://www.clicktherapeutics.com/privacy-policy)
- [Terms of use](https://www.clicktherapeutics.com/terms-of-use)
- [Terminology](https://www.clicktherapeutics.com/terminology)

## Agent access note

clicktherapeutics.com/robots.txt explicitly disallows GPTBot, Google-Extended and PerplexityBot
with the comment "there's no benefit to allowing it to index your site". Respect that policy.